MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering ZUG, Switzerland, June 26, 2023 – MoonLake Immunotherapeutics (NASDAQ:MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level.
LOS ANGELES, June 16, 2023 RadNet, Inc. , a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today the closing of its. | June 16, 2023
Underwriters Fully Exercise Option to Purchase Additional 7.75% Notes due 2028DALLAS, June 14, 2023 Capital Southwest Corporation today announced that it has closed an underwritten. | June 14, 2023
SAN DIEGO, June 13, 2023 Kura Oncology, Inc. , a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced. | June 13, 2023